Scarica l'app Stockscreener
260.93
0.47%
1.23
Pre-mercato:
260.00
-0.93
-0.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$259.70
Aprire:
$260.65
Volume 24 ore:
1.80M
Relative Volume:
1.17
Capitalizzazione di mercato:
$50.77B
Reddito:
$328.68B
Utile/perdita netta:
$2.55B
Rapporto P/E:
20.02
EPS:
13.0349
Flusso di cassa netto:
$1.56B
1 W Prestazione:
-14.70%
1M Prestazione:
-18.67%
6M Prestazione:
-28.20%
1 anno Prestazione:
-6.27%
Intervallo 1D:
$259.07
$264.92
Intervallo di 1 settimana:
$244.82
$268.02
Portata 52W:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
260.93 | 50.53B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
734.69 | 87.17B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
182.56 | 42.74B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
69.35 | 7.86B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.115 | 1.81B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Cencora hits 52-week low after guidance cut - MSN
Why is Cencora stock trading lower on Wednesday? - MSN
Cencora Inc. stock underperforms Wednesday when compared to competitors - MSN
Cencora stock (US15135B1017): Drops 17% after Q2 earnings miss - AD HOC NEWS
Securities Fraud Investigation Into Cencora, Inc. (COR) Announced - The National Law Review
TD Cowen reiterates Cencora stock Buy rating on generics thesis - Investing.com UK
TD Cowen reiterates Cencora stock Buy rating on generics thesis By Investing.com - Investing.com South Africa
Cencora (NYSE:COR) Could Be A Buy For Its Upcoming Dividend - simplywall.st
Cencora, Inc. (COR) Stock Analysis: A 36.74% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews
Cencora Inc. stock (US15135B1017): Healthcare distribution leader posts solid Q2 results - AD HOC NEWS
Cencora Q2 Earnings Call Highlights - Yahoo Finance
MSN Money - MSN
Can Cencora (COR) Sustain Its Margin Gains While Accepting Slower Revenue Growth? - simplywall.st
Cencora (COR) Q2 2026 EPS Surge Tests Bullish Earnings Growth Narratives - Sahm
Cencora Inc. stock (US15135B1017): Shares plunge after earnings and securities probe news - AD HOC NEWS
Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - ChartMill
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc. Stock (US15135B1017): Q2 2026 Earnings Miss Weighs on Shares - AD HOC NEWS
McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says - Moomoo
Cencora, Inc. Stock 12‑Month Price Target Cut to $365.17, Implies 43% Upside - TradingView
Cencora Earnings Review: The Selloff Was Overdone In My View (NYSE:COR) - Seeking Alpha
Why Is Cencora Stock Trading Lower On Wednesday? - Sahm
Is Cencora (COR) Prioritizing Margin Expansion Over Growth With Its Raised EPS Outlook and Buybacks? - Yahoo Finance
UBS Adjusts Price Target on Cencora to $412 From $410, Maintains Buy Rating - Moomoo
Cencora Q2 FY2026 slides: strategic moves amid revenue miss By Investing.com - Investing.com Australia
Cencora lifts 2026 outlook after OneOncology-fueled earnings jump - The Globe and Mail
Cencora Inc stock hits 52-week low at $265.50 By Investing.com - Investing.com Canada
Cencora: Fiscal Q2 Earnings Snapshot - theheraldreview.com
Cencora (COR) Valuation Check As Earnings Growth Follows Specialty Pharma And Acquisition Gains - simplywall.st
Cencora Earnings Call: Profit Strength Amid Revenue Reset - TipRanks
Cencora (COR) Raises 2026 EPS Outlook After Revenue Miss as International Growth Outpaces Domestic - AlphaStreet
Cencora raises annual guidance despite quarterly miss - marketscreener.com
Cencora Plunges 17.7% Amid Sector-Wide Selling - AlphaStreet
Cencora (COR) Q2 2026 Earnings Call Transcript - Fortune
Cencora, Inc. 2Q 2026: Revenue $78.36B, EPS $8.4— 10-Q Summary - TradingView
Oncology acquisitions lift Cencora (NYSE: COR) Q2 2026 profit and revenue - Stock Titan
Cencora, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 - marketscreener.com
Pricing Headwinds and Industry Trends Cut Into Cencora's 2026 Sales, but Fundamentals Remain Strong - Morningstar
Cencora, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Cencora Q2 FY2026 slides: strategic moves amid revenue miss - Investing.com
COR Stock Falls on Q2 Earnings & Revenue Miss, FY26 EPS View Raised - TradingView
Earnings call transcript: Cencora Inc. Q2 2026 misses estimates, stock drops - Investing.com
Cencora Down Over 18%, on Pace for Largest Percent Decrease Since October 1999 -- Data Talk - Moomoo
Transcript : Cencora, Inc., Q2 2026 Earnings Call, May 06, 2026 - marketscreener.com
Cencora, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:COR) 2026-05-06 - Seeking Alpha
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
17.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):